Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (14)
  • Antithrombotics (367)
    • Drug-Induced Thrombosis (32)
    • Prevention (38)
    • Reversal (15)
    • Treatment (336)
      • Apixaban (Eliquis) (86)
      • Aspirin (179)
      • Clopidogrel (Plavix) (116)
      • Dabigatran (Pradaxa) (113)
      • Edoxaban (Savaysa) (27)
      • Low Molecular Weight Heparins (67)
      • Other (53)
      • Prasugrel (Effient) (50)
      • Rivaroxaban (Xarelto) (111)
      • Ticagrelor (Brilinta) (32)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (37)
      • Warfarin - Treatment (162)
  • Arrhythmias (177)
  • Blood Pressure (30)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (57)
  • Dyslipidemia (270)
  • Endocarditis (20)
  • Heart Disease (78)
  • Heart Failure (183)
  • Hypertension (303)
  • Hypotension (19)
  • Ischemic Heart Disease/Acute Coronary Syndromes (354)
  • Myocardial Infarction (42)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (1)
  • Resources (901)
  • Stroke (170)
106 - 120 of 336 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Watch for Direct Oral Anticoagulant (Pradaxa, etc) Drug Interactions May 2016
Patient Education: What You Should Know About Proton Pump Inhibitors March 2016
Article: Don't Assume DOACs are Preferred for All Patients with Venous Thromboembolism March 2016
PL Voices: Restarting Anticoagulation in Atrial Fibrillation After a GI Bleed February 2016
Article: Don't Delay Restarting Anticoagulation in Atrial Fib Patients After GI Bleeding February 2016
Article: Reassure Stent Patients that Clopidogrel is an Important Heart Med January 2016
Other: Safety of Long-Term Treatment with Clopidogrel (Plavix) January 2016
PL Voices: Duration of Dual Antiplatelet Therapy January 2016
Commentary: Drug Interaction: Clopidogrel (Plavix) and Repaglinide (GlucoNorm) October 2015
Article: Stop Repaglinide and Switch to Another Diabetes Med in Clopidogrel Patients October 2015
Article: Use a Checklist to Help Patients Safely use DOACs October 2015
PL Voices: Monitoring Direct Oral Anticoagulants October 2015
Commentary: Oral Anticoagulants: Maximizing Safety October 2015
Checklist: Monitoring Checklist for the New Oral Anticoagulants October 2015
PL Voices: How to Choose an Antiplatelet Agent to Prevent Recurrent Stroke September 2015
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved